SearchDictionaryMobileLogin

Thomas J Walsh Selected Research

Infection

06/2008Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
03/2008Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
02/2007Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
12/2006Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection.
02/2006Immunotherapy for fungal infections.
02/2006Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.
01/2006Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
08/2005Posaconazole: clinical pharmacology and potential for management of fungal infections.
06/2005Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.
02/2005Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.
02/2005Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
11/2004Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
08/2004Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children.
05/2003Voriconazole treatment for less-common, emerging, or refractory fungal infections.
02/2003Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.
03/2002Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.

Articles by Research Topic

Disease

16Aspergillosis
09/2008 - 01/2002
16Infection
06/2008 - 03/2002
15Candidiasis (Moniliasis)
10/2007 - 05/2002
8Neutropenia
02/2007 - 01/2002
2Neoplasms (Cancer)
06/2008 - 02/2007
2Chronic Granulomatous Disease
02/2006 - 06/2005
2Fever (Fevers)
09/2004 - 01/2002
1Mycoses (Diseases, Fungus)
06/2008
1Abdominal Pain (Pain, Abdominal)
03/2008
1Meningoencephalitis
01/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2007
1Kidney Failure (Renal Failure)
07/2005
1Meningitis
06/2003
1Leukemia
04/2003

Drug/Important Bio-Agent (IBA)

7galactomannanIBA
09/2008 - 01/2002
6caspofungin (Cancidas)FDA Link
09/2007 - 01/2002
5micafungin (FK463)FDA Link
01/2008 - 06/2002
5Fluconazole (Zonal)FDA LinkGeneric
06/2007 - 09/2004
5voriconazole (Vfend)FDA Link
04/2007 - 01/2002
5posaconazoleFDA Link
01/2007 - 06/2005
4Amphotericin B (Amphotericin)FDA LinkGeneric
10/2007 - 07/2003
3anidulafunginFDA Link
06/2007 - 09/2004
3liposomal amphotericin BFDA Link
04/2007 - 01/2002
2Antifungal AgentsIBA
02/2007 - 01/2007
2PLD118IBA
05/2005 - 10/2004
2Isoleucine-tRNA LigaseIBA
05/2005 - 10/2004
1Sodium Glutamate (Accent)IBA
06/2008
1HormonesIBA
03/2008
1Triad resinIBA
03/2008
1Flucytosine (Ancobon)FDA Link
10/2007
1Itraconazole (Sporanox)FDA LinkGeneric
01/2007
1AntigensIBA
01/2007
1DNA (Deoxyribonucleic Acid)IBA
01/2006
1Interferon-gamma (Interferon, gamma)IBA
08/2004
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
08/2004
1ER 30346 (ravuconazole)IBA
04/2004
1Lysine (L-Lysine)FDA Link
04/2004
1Interleukin-4 (Interleukin 4)IBA
04/2003
1EchinocandinsIBA
12/2002
1cyclodextrin itraconazoleIBA
08/2002

Therapy/Procedure

2Hematopoietic Stem Cell Transplantation
03/2008 - 11/2004
2Transplantation (Transplant Recipients)
02/2007 - 02/2005
2Salvage Therapy
12/2006 - 06/2005
1Immunotherapy
02/2006
1Renal Dialysis (Hemodialysis)
07/2005
1Neonatal Intensive Care
02/2003
1Highly Active Antiretroviral Therapy (HAART)
05/2002